Table 3.
Short- and long-term MACEs
| Variables | Total (n = 392) | Flow of the main diagonal branches of LAD | p Value | |
|---|---|---|---|---|
| loss (TIMI 0–1) (n = 69) | no loss (TIMI2–3) (n = 323) | |||
| In-hospital MACEs | 19(4.8) | 10(14.5) | 9(2.8) | 0.001 |
| All-cause mortality, n(%) | 19(4.8) | 10(14.5) | 9(2.8) | 0.001 |
| Cardiac mortality, n(%) | 13(3.3) | 10(14.5) | 3(0.9) | 0.001 |
| TVR, n(%) | 0 | 0 | 0 | / |
| Recurrent myocardial infarction, n(%) | 0 | 0 | 0 | / |
| 1-month MACEs | 23(5.9) | 10(14.5) | 13(4) | 0.003 |
| All-cause mortality, n(%) | 19(4.8) | 10(14.5) | 9(2.8) | 0.001 |
| Cardiac mortality, n(%) | 13(3.3) | 10(14.5) | 3(0.9) | 0.001 |
| TVR, n(%) | 1(0.3) | 0 | 1(0.3) | 1 |
| Recurrent myocardial infarction, n(%) | 3(0.8) | 0 | 3(0.9) | 1 |
| 18-month MACEs | 38(9.7) | 12(17.4) | 26(8) | 0.02 |
| All-cause mortality, n(%) | 24(6.1) | 12(17.4) | 12(3.7) | 0.001 |
| Cardiac mortality, n(%) | 16(4.1) | 10(14.5) | 6(1.9) | 0.001 |
| TVR, n(%) | 3(0.8) | 0 | 3(0.9) | 1 |
| Recurrent myocardial infarction, n(%) | 11(2.8) | 0 | 11(3.4) | 0.23 |
| 18-month MACEs (landmark analysisa) | 15(4.1) | 2(3.4) | 13(4.2) | 0.77 |
| All-cause mortality, n(%) | 5(1.4) | 2(3.4) | 3(0.9) | 0.21 |
| Cardiac mortality, n(%) | 3(0.8) | 0 | 3(0.9) | 1 |
| TVR, n(%) | 2(0.5) | 0 | 2(0.7) | 1 |
| Recurrent myocardial infarction, n(%) | 8(2.2) | 0 | 8(2.6) | 0.37 |
| 18-month MACEs (landmark analysisb) | 19(5.1) | 2(3.4) | 17(5.4) | 0.74 |
| All-cause mortality, n(%) | 5(1.3) | 2(3.4) | 3(0.9) | 0.38 |
| Cardiac mortality, n(%) | 3(0.8) | 0 | 3(0.9) | 1 |
| TVR, n(%) | 3(0.8) | 0 | 3(0.9) | 1 |
| Recurrent myocardial infarction, n(%) | 11(2.9) | 0 | 11(3.5) | 0.23 |
aanalysis starting from 1 month to 18 months. banalysis starting from the time of discharged the hospital to 18 months. LAD Left anterior descending artery, MACEs Major adverse cardiac events, TVR Target vessel revascularization